Manufacturer or GPO Program year 2025 Source: CMS Open Payments

Emergent BioSolutions Inc.

MD, United States

CMS manufacturer 100000011074

Open in the dashboard

General payments

$1,835,057

1,625 payments

Research payments

$71,014,766

36,425 payments

Ownership & investment interest

$0

None reported

Through program year 2025, Emergent BioSolutions Inc. reported paying $1,835,057 in general payments and $71,014,766 in research payments to U.S. physicians, teaching hospitals and other recipients.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

14 rows
Year Kind Amount Payments
2025 General $134,572 117
2025 Research $350,945 19
2024 General $6,832 4
2024 Research $435,321 24
2023 General $191,851 64
2023 Research $4,762,015 146
2022 General $346,472 124
2022 Research $25,330,597 698
2021 General $436,290 334
2021 Research $6,721,424 316
2020 General $392,932 232
2020 Research $6,322,359 9,999
2019 General $326,108 750
2019 Research $27,092,104 25,223

Breakdown

Top recipients General payments · program year 2025
  1. James McCarty Pediatric Infectious Diseases · Madera, CA $47,122 11 payments
  2. Jake Goodman Psychiatry · Poway, CA $15,000 1 payment
  3. Anna Durbin Infectious Disease · Baltimore, MD $10,509 12 payments
  4. Shirit Einav Infectious Disease · Palo Alto, CA $9,223 16 payments
  5. Inger Damon Internal Medicine · Atlanta, GA $9,017 14 payments
  6. Anita Gupta Pain Medicine · San Diego, CA $8,167 11 payments
  7. Daniel Ciccarone Family Medicine · San Francisco, CA $6,338 10 payments
  8. Steven Stanos Pain Medicine · Seattle, WA $6,027 9 payments
  9. Sandra Springer Internal Medicine · New Haven, CT $5,348 13 payments
  10. Stephen Taylor Addiction Medicine · Birmingham, AL $5,110 7 payments
Top research recipients Research payments · program year 2025
  1. The University Of Texas Medical Br. Teaching hospital · TX $190,304 2 payments
  2. James McCarty Pediatric Infectious Diseases · Madera, CA $160,641 17 payments
Products the payments named General payments · program year 2025
  1. Acam2000 Smallpox $40,513 73% · 1 recipient
  2. Narcan Antidotes $15,000 27% · 1 recipient

Each share is of this company’s general payments naming a product in 2025. A payment can name up to five products, so these amounts overlap.

Specialties paid General payments · program year 2025
  1. Pediatric Infectious Diseases Pediatrics $47,122 35% · 1 practitioner
  2. Infectious Disease Internal Medicine $26,910 20% · 4 practitioners
  3. Psychiatry Psychiatry & Neurology $15,000 11% · 1 practitioner
  4. Internal Medicine $14,365 11% · 2 practitioners
  5. Pain Medicine Anesthesiology $8,167 6% · 1 practitioner

The top 5 of 12 specialties; each share is of this company’s general payments to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $85,850 64% · 5 recipients
  2. Georgia $11,845 9% · 2 recipients
  3. Maryland $11,045 8% · 3 recipients
  4. Washington $6,027 4% · 1 recipient
  5. Connecticut $5,348 4% · 1 recipient

The top 5 of 8 states; each share is of this company’s general payments in 2025 where a state was reported.

The top 25 states, free in the app

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $1,465,355 526 payments
  2. Honoraria $129,209 50 payments
  3. Royalty or License $89,718 3 payments
  4. Travel and Lodging $52,993 181 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $50,819 10 payments
  6. Food and Beverage $43,462 853 payments
  7. Grant $3,500 2 payments
1,625 general · 36,425 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers of drugs, devices and biologicals, and group purchasing organisations, are required to report the payments and transfers of value they make to physicians and teaching hospitals. This page shows what this company reported.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record